Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay
about
HIV/AIDS epidemiology, pathogenesis, prevention, and treatmentUse of phylogenetics in the molecular epidemiology and evolutionary studies of viral infections.Advances in developing HIV-1 viral load assays for resource-limited settingsMonitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assayHIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assaysDetection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method.Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, UgandaUse of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burdenTwo types of nanoparticle-based bio-barcode amplification assays to detect HIV-1 p24 antigen.Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?Role of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosis.Detection of HIV-1 p24 antigen in patients with varying degrees of viremia using an ELISA with a photochemical signal amplification system.Increased Sensitivity of HIV-1 p24 ELISA Using a Photochemical Signal Amplification System.Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.Monocytes but Not Lymphocytes Carrying HIV-1 on Their Surface Transmit Infection to Human Tissue Ex Vivo.Comparative evaluation of the ExaVir Load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load.Assessment of the low-cost Cavidi ExaVir Load assay for monitoring HIV viral load in pediatric and adult patients.The performance of reverse transcriptase assay for the estimation of the plasma viral load in HIV-1 and HIV-2 infections.Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions.Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients.Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.The importance of caregivers in the outcome of pediatric HIV management, Mombasa, Kenya.A model for reduced HIV-1 viral load monitoring in resource-limited settings.HIV viral load monitoring in resource-limited regions: optional or necessary?
P2860
Q30356074-78FB19E3-9A8F-4EF8-AB4C-7F4836E39B23Q30387664-B94CDA5E-D5A5-4719-8488-88604C482E3BQ30473238-E912510D-6CA0-43DB-AE80-781A7DBE4254Q33497943-3685AAB1-EFAF-427F-AEED-4B3A6E563202Q33636945-83DF19CF-4C00-452B-A58A-BCE264F15F89Q33652072-4861117C-CEF7-46DD-B9BE-36BA1E706A06Q34514881-F1471A5B-3837-44F4-9C5D-D5CCC641190CQ35678689-D00E1F77-39FB-45F2-AB99-0951CA9A41ACQ35690718-A0225DE6-9014-466F-8A73-C1E37BBED4FFQ36394635-6BA91996-32B5-4F2E-8F6D-78ADED8FEB89Q36526686-E74082ED-30D2-4AFC-A7AC-28F38F48E1F6Q36914872-897E3AB6-6D9C-411F-B568-FB0C86D7C91DQ37067960-FAF0DD72-F794-412F-AF87-72A9B28BDF40Q37140373-3F9574B3-F3DC-4852-8D27-0A6E71ABDFE3Q37333664-B5993F8F-3147-4658-A163-FC4A7F5AD82DQ37347339-6A95F550-D6D2-4844-875A-31703820558CQ37374897-40E2A2E5-F92E-42EC-8FE0-CA753C1B38A9Q37441641-15D98720-5CBD-4DBC-889E-494BB537801DQ38384495-62F3C651-941E-4247-BDBA-BF0548A822E9Q38790676-FE0838C2-4FFF-467B-9AEC-665CC250FD01Q40197811-5CD8A48E-7F35-4279-AAA8-DDB3619C65EDQ41941058-88467D58-14EA-4F18-9194-9F320A764190Q42265058-74A70728-E9EA-4E37-8281-3018C1261F8CQ44265409-75830CAF-D316-4D57-8DF6-564F7772F925Q44629379-EED4B2F4-0132-4422-81DA-60E70E2B0B1E
P2860
Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Comparison of two human immuno ...... to the standard HIV RNA assay
@ast
Comparison of two human immuno ...... to the standard HIV RNA assay
@en
Comparison of two human immuno ...... to the standard HIV RNA assay
@en-gb
Comparison of two human immuno ...... to the standard HIV RNA assay
@nl
type
label
Comparison of two human immuno ...... to the standard HIV RNA assay
@ast
Comparison of two human immuno ...... to the standard HIV RNA assay
@en
Comparison of two human immuno ...... to the standard HIV RNA assay
@en-gb
Comparison of two human immuno ...... to the standard HIV RNA assay
@nl
prefLabel
Comparison of two human immuno ...... to the standard HIV RNA assay
@ast
Comparison of two human immuno ...... to the standard HIV RNA assay
@en
Comparison of two human immuno ...... to the standard HIV RNA assay
@en-gb
Comparison of two human immuno ...... to the standard HIV RNA assay
@nl
P2093
P2860
P1476
Comparison of two human immuno ...... to the standard HIV RNA assay
@en
P2093
Ada Cachafeiro
Aleksandra D Danilovic
Cheryl Jennings
Donald J Brambilla
Gary E Corrigan
J Simon Gronowitz
James W Bremer
Jorg Schupbach
Michael A Ussery
Oliviero E Varnier
P2860
P304
P356
10.1128/JCM.43.12.5950-5956.2005
P407
P577
2005-12-01T00:00:00Z